4-[(1R)-1-[5-(cyclopropylmethoxy)-2-pyridinyl]propoxy]-N-(4-ethylpiperazin-1-yl)sulfonyl-2,3-difluorobenzamide
C25H32F2N4O5S — CID 176878818
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[(1R)-1-[5-(cyclopropylmethoxy)-2-pyridinyl]propoxy]-N-(4-ethylpiperazin-1-yl)sulfonyl-2,3-difluorobenzamide
4-[(1R)-1-[5-(cyclopropylmethoxy)-2-pyridinyl]propoxy]-N-(4-ethylpiperazin-1-yl)sulfonyl-2,3-difluorobenzamide (PubChem CID 176878818) has the molecular formula C25H32F2N4O5S and a molecular weight of 538.62 g/mol. Its IUPAC name is 4-[(1R)-1-[5-(cyclopropylmethoxy)-2-pyridinyl]propoxy]-N-(4-ethylpiperazin-1-yl)sulfonyl-2,3-difluorobenzamide.
Molecular Properties
| Compound Name | 4-[(1R)-1-[5-(cyclopropylmethoxy)-2-pyridinyl]propoxy]-N-(4-ethylpiperazin-1-yl)sulfonyl-2,3-difluorobenzamide |
|---|---|
| PubChem CID | 176878818 |
| Molecular Formula | C25H32F2N4O5S |
| Molecular Weight | 538.62 g/mol |
| Exact Mass | 538.21 |
| IUPAC Name | 4-[(1R)-1-[5-(cyclopropylmethoxy)-2-pyridinyl]propoxy]-N-(4-ethylpiperazin-1-yl)sulfonyl-2,3-difluorobenzamide |
| SMILES | CC[C@@H](Oc1ccc(C(=O)NS(=O)(=O)N2CCN(CC)CC2)c(F)c1F)c1ccc(OCC2CC2)cn1 |
| InChI | InChI=1S/C25H32F2N4O5S/c1-3-21(20-9-7-18(15-28-20)35-16-17-5-6-17)36-22-10-8-19(23(26)24(22)27)25(32)29-37(33,34)31-13-11-30(4-2)12-14-31/h7-10,15,17,21H,3-6,11-14,16H2,1-2H3,(H,29,32)/t21-/m1/s1 |
| InChIKey | JAHDYLVIVLAJCI-OAQYLSRUSA-N |
| XLogP | 3.29 |
| TPSA | 101.07 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 538.62 |
| LogP ≤ 5 | 3.29 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176878818 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.